Literature DB >> 23113186

Psychosocial disabilities in patients with schizophrenia.

Ma Goreishizadeh1, A Mohagheghi, S Farhang, L Alizadeh.   

Abstract

BACKGROUND: This study aimed at revaluating the psychosocial disabilities in schizophrenic patients.
METHODS: In an analytic-descriptive setting, schizophrenic patients were evaluated in Razi University Hospital during a one-year period (2009-10). The study group consisted of male and female patients aged 18-65 years, with the onset of disease for a minimum of 2 years and at least one psychological hospitalization in their medical record. The demographic data, as well as the results of the SANS, SAPS, GARF and SOFAS questionnaires were determined in each patient.
RESULTS: Two hundred and eight patients, 53 females, and 155 males with the mean age of 36.96±11.55 (18-65) years were enrolled. Vocational, educational, social, familial, and self-hygiene related disabilities were seen in 63.5%, 21.2%, 93.8%, 13.9%, and 48.1% of the patients, respectively. Totally, psychosocial disabilities were reported in 98.1% of these patients. The mean age of the patients with educational or social disabilities was lower. Vocational problems were more common in male patients. Familial and social disabilities were positively related to the severity of positive and negative symptoms, with the predominance of the latter. Positive and negative symptoms were more frequent in patients with social and self-care related disabilities, respectively. The duration of the disease was significantly correlated with the positive symptoms and familial-social disabilities.
CONCLUSION: The current study described the high prevalence of psychosocial disabilities in patients with schizophrenia and may have implications for public health interventions.

Entities:  

Keywords:  Iran; Psychosocial disabilities; Schizophrenia

Year:  2012        PMID: 23113186      PMCID: PMC3468984     

Source DB:  PubMed          Journal:  Iran J Public Health        ISSN: 2251-6085            Impact factor:   1.429


Introduction

Schizophrenia is known as a chronic syndrome with a variable, but always destructive, pattern affecting the perceptual, cognitive, and emotional aspects of the affected patients (1). The symptoms vary among patients but the sequels are generally considerable and persistent (2). The disorder, generally beginning at adulthood, initiates with the positive (delusions, hallucinations, disorganized speech and behavior) and negative signs and symptoms (avolition, isolation, restricted memory and poverty of speech). The positive symptoms dilute during the remission phase where the negative symptoms and social isolation become the most dominant features (1, 3). Regardless its well known etiology, the disorder has a big load of cost for the community. Schizophrenia has costs the United States an annual rate of 33 milliard dollars for its direct and indirect expenditure which is more than the whole cost for all kind of cancers (1). Patients with schizophrenia bear the “stigma” of this disorder as well. Most of them feel to be “different”, “insufficient” or “incomplete”. Some studies tried to find the effective factors for occupational success for these patients (4). They are mostly unable to perform in occupations requiring the contest with no formal support. They generally loose the capacity to promote or gain educational opportunities and thus fail to reach a desirable function in individual jobs either. A German study demonstrated that 90% of these patients have social dysfunction (5). In US, 45% of homeless people are patients with schizophrenia (1). Other studies from different populations and different types of schizophrenia have reported social dysfunction to be present in 50 to 87.5% (6–13). Psychosocial disabilities and social dysfunctions have a great impact on patients with schizophrenia. While antipsychotic medications affect the positive and negative symptoms and do not directly decrease the social disabilities, such patients need rehabilitative and supportive programs. There is a serious lack of information regarding this point of view in Iran. The first step is to map the burden of the consequences that patients with schizophrenia are facing. The aim of the current study was to evaluate the psychosocial disabilities of these patients in our community.

Materials and Methods

The study was carried out during the year 2009–2010 in Razi Hospital, Tabriz University of Medical Sciences, Iran. The in-patients were diagnosed as having schizophrenia according to a structured interview based on the fourth edition of the diagnostic and Statistical Manual of Mental Disorders (DSM IV-TR). Patients were included if the symptoms were present for at least 2 years and they had the history of at least one hospital admission. The current function of patients was evaluated by Social and Occupational Functioning Assessment Scale (SOFAS). The overall evaluation about the function of the family or other persistent relationships was made by Global Assessment of Relational Functioning (GARF). The Scale for Assessment of Negative Symptoms (SANS) and Scale for Assessment of positive Symptoms (SAPS) were used for scoring negative and positive symptoms of patients with schizophrenia as described above. These well-known standard questionnaires are being used in different nations and the validity and reliability of the tests are described elsewhere (3). Substance related problems, personality disorder, mental retardation and another psychiatric diagnosis on axis one resulted in exclusion from the study. The protocol was approved by regional Ethnic Committee and information of patients was kept secured. The data were included in the study after a written consent from care givers of the patients. No intervention was done because of this study and patients received their appropriate treatment independent form these results. Statistical analysis was performed using Statistical Package for the Social Sciences (SPSS, version 13.0). The χ2 test, t test, and fisher’s exact were used for comparisons between groups, as appropriate. The level of significance was set at P<0.05.

Results

Out of 208 cases, 53(24.5%) were female and 155(74.5%) were male. The mean age (SD) was 36.96 (11.55) yr. Characteristics of the study population are described in Table 1. To distinguish the function of female patients fifteen females who could not perform their house works were considered unemployed.
Table 1:

Characteristics of the study population

n (% of total) or mean (SD)
Marital statusSingle109 (52.4)
Married64 (30.8)
Divorced31 (14.9)
Widowed4 (1.9)
Occupational statusUnemployed67 (32.2)
Housewife (females)38 (18.3)
Official work11 (5.3)
Self employment (males)45 (21.6)
Farmer/workman47 (22.6)
Duration of education (years)6.41 (4.85)
Previous hospitalization3.12 (1.62)
Duration of schizophrenia (months)11.38 (8.66)
SANS *60.55 (23.440
SAPS 61.81 (23.57)
GARF 35.58 (12.19)
SOFAS **36.89 (15.30)

Scale for Assessment of Negative Symptoms

Scale for Assessment of Positive Symptoms

Global Assessment of Relational Functioning

Social and Occupational Functioning Assessment Scale

The most common psychosocial disability faced by these patients was disability in social functioning (93.75%), followed by occupational problems (63.46%), poor personal health maintenance (48.08%), educational problems (21.15%) and divorce or other family problems (13.9%) while only 1.92% had no psychosocial disabilities. The duration of the illness was positively correlated with positive symptoms (P=0.025, r=0.155) and negatively correlated with score of GARF (P=0.033, r=0.148) and SOFAS (P=0.0.037, r=0.144). The scores of GARF and SOFAS were negatively correlated with positive and (to a stronger degree with) negative symptoms (P<0.001, r=0.563). Negative symptoms were correlated with poor self-care (P<0.001). Younger patients were more subject to educational problems (P<0.001). Considering being a “housewife” as a job for females, occupational problems were more reported for men (P=0.004). The other factors related to family problems and social disabilities are described in Table 2 and 3.
Table 2:

Factors related to family problems including divorce in patients with schizophrenia, as mean (SD)

No family problems n=179With family problems n=29P
GenderFemale44(24.6%)9(31.0%)0.493
Male135(75.4%)20(69.0%)
History of hospitalizationOne41(22.9%)9(31.0%)0.761
Two34(19.0%)5(17.2%)
Three26(14.5%)2(6.9%)
≥Four78(43.5%)13(44.8%)
Age (yr)36.45(11.55)40.14(11.24)0.111
Duration of illness (months)11.36(8.91)11.48(7.05)0.945
Duration of education(yr)6.50(4.78)5.86(4.80)0.511
Negative symptoms59.97(23.80)64.14(21.16)0.376
Positive symptoms60.64(23.63)69.10(22.24)0.074
Table 3:

Factors related to social problems in patients with schizophrenia, as mean (SD)

No social problems n=13With social problems n=195P
GenderFemale2(15.4%)51(26.2%)0.523
Male11(84.6%)144(73.8%)
Marital statusSingle5(22.9%)104(53.3%)0.644
Married5(19.0%)59(30.3%)
Divorced3(14.5%)28(14.4%)
widowed02(2.1%)
History of hospitalizationOne1(7.7%)49(25.0%)0.223
Two4(30.8%)35(17.9%)
Three1(7.7%)27(13.8%)
≥Four019(9.7%)
Age (yr)46.38(15.04)36.66(11.04)0.002
Duration of illness (months)12.46(9.40)11.31(8.63)0.643
Duration of education (yr)6.31(5.00)6.42(4.86)0.936
Negative symptoms56.38(22.29)60.83(23.55)0.509
Positive symptoms44.38(19.86)62.97(23.38)0.006

Discussion

The current study evaluated psychosocial disabilities in patients with schizophrenia, which in the best of our knowledge is the first report from Iran. Disturbance in social functioning was observed in 93.8% of our study population, which is compatible with other reports form different countries. Occupational disabilities have been reported in 66 to 77% of these patients in different reports (14–17) which was observe din 63.5% of our study population as well. Despite one study reporting no correlation between the age of onset and social disability (18) most of the reports consider younger age of onset as a prognostic factor for later problems in social functioning (19) which was obvious in the current study as well. It may be explained by a more psychological demolition in a longer duration (1, 3). The other finding that was compatible with previous reports again, was the effect of duration of illness on decreasing familial and social functioning (scored by SOFAS and GARF) (20–23). In general, a worse outcome is predicted for men compared to women with schizophrenia (1, 3, 24). However; the current study reported only reduced occupational function for men. This is largely influenced by the fact that men are mostly supposed to have a career out of home in the culture of this country. Moreover, the current study did not evaluate the overall outcome and prognosis of patients, which may be the same between different populations. The negative correlation between (especially) negative and positive symptoms is described in other reports as well (25–28). Only one study reported a same value for these two types of symptoms (29) which both had a negative correlation with function of patients. In conclusion, the current study emphasized the considerable psychosocial disability among Iranian patients with schizophrenia (influenced by negative and positive symptoms of the disorder) wasting a part of the productive population as well as costs of the disorder. It seems that together with the effective pharmacological treatments, the public and these patients will benefit from psychoeducation to family, and educating different occupational and social skills to patients.

Ethical considerations

Ethical issues (Including plagiarism, Informed Consent, misconduct, data fabrication and/or falsification, double publication and/or submission, redundancy, etc) have been completely observed by the authors.
  26 in total

1.  Remission and relapse in the outpatient care of schizophrenia: three-year results from the Schizophrenia Outpatient Health Outcomes study.

Authors:  Josep Maria Haro; Diego Novick; David Suarez; Jordi Alonso; Jean Pierre Lépine; Mark Ratcliffe
Journal:  J Clin Psychopharmacol       Date:  2006-12       Impact factor: 3.153

2.  Clinical epidemiologic first-episode psychosis: 1-year outcome and predictors.

Authors:  E Simonsen; S Friis; U Haahr; J O Johannessen; T K Larsen; I Melle; S Opjordsmoen; B R Rund; P Vaglum; T McGlashan
Journal:  Acta Psychiatr Scand       Date:  2007-07       Impact factor: 6.392

3.  Natural course of schizophrenia: 2-year follow-up study in a rural Chinese community.

Authors:  M Ran; M Xiang; M Huang; Y Shan
Journal:  Br J Psychiatry       Date:  2001-02       Impact factor: 9.319

Review 4.  Schizophrenia.

Authors:  W T Carpenter; R W Buchanan
Journal:  N Engl J Med       Date:  1994-03-10       Impact factor: 91.245

5.  Community dysfunction in schizophrenia: rate-limiting factors.

Authors:  Vasilis P Bozikas; Mary H Kosmidis; Anna Kafantari; Katerina Gamvrula; Eleni Vasiliadou; Petros Petrikis; Kostas Fokas; Athanasios Karavatos
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-01-25       Impact factor: 5.067

6.  Long-term trends of symptoms and disability in schizophrenia and related disorders.

Authors:  K Ganev
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2000-09       Impact factor: 4.328

7.  The psychosocial outcome of adolescent-onset schizophrenia: a 12-year followup.

Authors:  B Lay; B Blanz; M Hartmann; M H Schmidt
Journal:  Schizophr Bull       Date:  2000       Impact factor: 9.306

8.  Social disability in schizophrenia: its development and prediction over 15 years in incidence cohorts in six European centres.

Authors:  D Wiersma; J Wanderling; E Dragomirecka; K Ganev; G Harrison; W An Der Heiden; F J Nienhuis; D Walsh
Journal:  Psychol Med       Date:  2000-09       Impact factor: 7.723

9.  Prevalence and stability of social skill deficits in schizophrenia.

Authors:  K T Mueser; A S Bellack; M S Douglas; R L Morrison
Journal:  Schizophr Res       Date:  1991-09       Impact factor: 4.939

10.  Premorbid, psychosocial and clinical predictors of the costs of schizophrenia and other psychoses.

Authors:  Vaughan J Carr; Terry J Lewin; Amanda L Neil; Sean A Halpin; Scott Holmes
Journal:  Br J Psychiatry       Date:  2004-06       Impact factor: 9.319

View more
  6 in total

1.  Effect of needs-assessment-based psychoeducation for families of patients with schizophrenia on quality of life of patients and their families: A controlled study.

Authors:  Viktoria Omranifard; Azam Yari; Gholam Reza Kheirabadi; Mahnaz Rafizadeh; Mohammad Reza Maracy; Sima Sadri
Journal:  J Educ Health Promot       Date:  2014-11-29

2.  Saliva secretion disorder in a schizophrenic patient - a problem in dental and psychiatric treatment: a case report.

Authors:  Danuta Maria Moś
Journal:  Ann Gen Psychiatry       Date:  2015-03-10       Impact factor: 3.455

3.  Effects of needs-assessment-based psycho-education of schizophrenic patients' families on the severity of symptoms and relapse rate of patients.

Authors:  Gholam Reza Kheirabadi; Mahnaz Rafizadeh; Victoria Omranifard; Azam Yari; Mohammad Reza Maracy; Tayebe Mehrabi; Sima Sadri
Journal:  Iran J Nurs Midwifery Res       Date:  2014-11

4.  An Observational Cohort of First Episode Psychosis in Iran: The Azeri Recent Onset Acute Phase Psychosis Survey (ARAS Cohort) Study Protocol.

Authors:  Sara Farhang; Mehrdad Ghaemmaghami; Ali Reza Shafiee-Kandjani; Seyed Gholamreza Noorazar; Wim Veling; Ayyoub Malek; Mohammad Hossein Somi; Richard Bruggeman; Behrooz Z Alizadeh
Journal:  Front Psychiatry       Date:  2021-02-10       Impact factor: 4.157

Review 5.  Schizophrenia relapse and the clinical usefulness of once-monthly aripiprazole depot injection.

Authors:  Sheng-Min Wang; Changsu Han; Soo-Jung Lee; Ashwin A Patkar; Prakash S Masand; Chi-Un Pae
Journal:  Neuropsychiatr Dis Treat       Date:  2014-08-30       Impact factor: 2.570

6.  The Influence of Psychosocial Dysfunctions in Chronic Schizophrenia Patients in Remission: A Hospital-Based Study.

Authors:  Sarada Prasanna Swain; Sushree Sangita Behura; Manoj Kumar Dash; Anil Kumar Nayak; Saswati Sucharita Pati
Journal:  Indian J Psychol Med       Date:  2017 Mar-Apr
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.